Troponin Elevation in the Elderly Patient With Hip Fracture
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00647309|
Recruitment Status : Unknown
Verified June 2012 by Dr. Marina Arad, Sheba Medical Center.
Recruitment status was: Recruiting
First Posted : March 31, 2008
Last Update Posted : June 12, 2012
Elevated troponin is powerful and independent adverse prognostic marker in patient with ACS. However, non specific (non cardiac) troponin elevation is a common finding among hospitalized patients and worse prognosis too.
The aim of this study is examine the prevalence of incidental cardiac troponin rise in a group of patient aged 65 and over admitted to geriatric department with hip fracture, and influence of troponin elevation on outcomes like ACS, death, motor and cognitive function.
|Condition or disease|
data collection will include epidemiological data (age, gender, living arrangement, basic functional status, fracture date, surgery date, surgery type, length of stay) as well as previous comorbidities. in addition, routine blood tests and baseline ECG will be recorded.
troponin levels will be studied within 24 hours from admission, and 24 hours following surgery. in case of elevated troponin levels, ECG will be repeated, and echocardiography together with a cardiologist evaluation will be carried out.
data regarding in-hospital complications, motor and cognitive function (by FIM scale) and lab will be recorded. after discharge. followup will be recorded every 3 months, up to 1 year period, recoding the above mentioned data.
|Study Type :||Observational|
|Estimated Enrollment :||100 participants|
|Official Title:||Correlation Between Troponin Level and Rehabilitation Outcome in Elderly Patient With Hip Fracture|
|Study Start Date :||April 2008|
|Estimated Primary Completion Date :||February 2013|
|Estimated Study Completion Date :||June 2013|
- all cause mortality, motor and cognitive function [ Time Frame: one year ]
Biospecimen Retention: Samples With DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00647309
|Sheba Medical Center, Geriatric Rehabilitation dept||Recruiting|
|Ramat Gan, Israel, 52621|
|Contact: Arad Marina, MD 973-3-5305108 firstname.lastname@example.org|
|Principal Investigator: arad marina, MD|
|Sub-Investigator: Adunsky Abraham, MD|
|Principal Investigator:||Marina Arad, MD||Sheba Medical Center|